Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11025736 | Biomedicine & Pharmacotherapy | 2018 | 8 Pages |
Abstract
MicroRNAs can exhibit opposite functions in different tumors. MiR-31 is a representative example as it can not only enhance tumor development and progression in pancreatic cancer, colorectal cancer and so on, but also inhibit tumorigenesis and induce apoptosis in ovarian cancer, prostate cancer and etc. The mechanism underlying its' pleiotropy remains unknown. Several recent studies that focused on the global gene expression changes caused by aberrant miR-31 provided information on the upstream and downstream events associated with deregulated miR-31. MiR-31 might interact with a number of signaling pathways including RAS/MARK, PI3K/AKT and RB/E2F to play its opposite functions. This review summarizes the target genes and pathways associated with miR-31 and examines the mechanisms underlying the function of miR-31. The resulting hypothesis is possible that the tissue-specific features of adenocarcinoma and squamous cell cancer and the positive feedback loop consists of miR-31 and its upstream and downstream may account for the diversity of miR-31 functions.
Keywords
NPCICCCrtISCsOACTFsBEREndMTHNSCCS1Pintegrin α5HIFMSIMMRESCCPKCεMLCCDK4HER-2GEFC-TADITGA5TNBCZn deficiencyFactor-inhibiting hypoxia-inducible factorDSBOPMDSCCOSCCMASCADCNERHCCPCATiam1AdenocarcinomaOesophageal adenocarcinomaSphingosine-1-phosphateEBVmiR-31Microsatellite instabilitynucleotide excision repairmismatch repairbase excision repairTumorigenesisEMTRISCmyosin light chainColorectal cancerNSCLCTriple negative breast cancerGastric cancerProstate cancerBreast cancerintestinal stem cellsFIHchemo-radiation therapyTranscription factorsHypoxia-inducible factorguanine nucleotide exchange factorVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)RNA-Induced Silencing ComplexPathwaysMicroRNAMiRNANucleotideEpstein-Barr virusretinoblastoma proteinProtein kinase C epsilonSquamous cell carcinomaoral squamous cell carcinomaHead and neck squamous cell carcinomaEsophageal squamous cell carcinomaHepatocellular carcinomaCRCIntrahepatic cholangiocarcinomacyclin-dependent kinase 4Epithelial-mesenchymal transitionEstrogen receptorProgesterone receptor
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tao Yu, Pei Ma, Deqin Wu, Yongqian Shu, Wen Gao,